Style | Citing Format |
---|---|
MLA | Rafiee M, et al.. "Vitamin D3 Induces the Expression of Membrane Progesterone Receptors (Mprs) on Naive Cd4 + T Lymphocyte Cells in Women of Reproductive Age." International Immunopharmacology, vol. 72, no. , 2019, pp. 55-61. |
APA | Rafiee M, Naseri M, Akbarifakhrabadi M, Motamedi N, Ghahiri A, Mehrabian F, Rezaei A (2019). Vitamin D3 Induces the Expression of Membrane Progesterone Receptors (Mprs) on Naive Cd4 + T Lymphocyte Cells in Women of Reproductive Age. International Immunopharmacology, 72(), 55-61. |
Chicago | Rafiee M, Naseri M, Akbarifakhrabadi M, Motamedi N, Ghahiri A, Mehrabian F, Rezaei A. "Vitamin D3 Induces the Expression of Membrane Progesterone Receptors (Mprs) on Naive Cd4 + T Lymphocyte Cells in Women of Reproductive Age." International Immunopharmacology 72, no. (2019): 55-61. |
Harvard | Rafiee M et al. (2019) 'Vitamin D3 Induces the Expression of Membrane Progesterone Receptors (Mprs) on Naive Cd4 + T Lymphocyte Cells in Women of Reproductive Age', International Immunopharmacology, 72(), pp. 55-61. |
Vancouver | Rafiee M, Naseri M, Akbarifakhrabadi M, Motamedi N, Ghahiri A, Mehrabian F, et al.. Vitamin D3 Induces the Expression of Membrane Progesterone Receptors (Mprs) on Naive Cd4 + T Lymphocyte Cells in Women of Reproductive Age. International Immunopharmacology. 2019;72():55-61. |
BibTex | @article{ author = {Rafiee M and Naseri M and Akbarifakhrabadi M and Motamedi N and Ghahiri A and Mehrabian F and Rezaei A}, title = {Vitamin D3 Induces the Expression of Membrane Progesterone Receptors (Mprs) on Naive Cd4 + T Lymphocyte Cells in Women of Reproductive Age}, journal = {International Immunopharmacology}, volume = {72}, number = {}, pages = {55-61}, year = {2019} } |
RIS | TY - JOUR AU - Rafiee M AU - Naseri M AU - Akbarifakhrabadi M AU - Motamedi N AU - Ghahiri A AU - Mehrabian F AU - Rezaei A TI - Vitamin D3 Induces the Expression of Membrane Progesterone Receptors (Mprs) on Naive Cd4 + T Lymphocyte Cells in Women of Reproductive Age JO - International Immunopharmacology VL - 72 IS - SP - 55 EP - 61 PY - 2019 ER - |